Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy.

Wang HJ, Ma C, Yang J, Xu Q, Zhang Y, Gao L, Xu B, Zhang YX, Li Y, Yin T.

J Geriatr Cardiol. 2012 Jun;9(2):209-10. doi: 10.3724/SP.J.1263.2012.04162. No abstract available.

2.

Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation.

Copland M, Walker ID, Tait RC.

Arch Intern Med. 2001 Sep 24;161(17):2125-8.

PMID:
11570942
3.

Comparative performance of warfarin pharmacogenetic algorithms in Chinese patients.

Liu Y, Yang J, Xu Q, Xu B, Gao L, Zhang Y, Zhang Y, Wang H, Lu C, Zhao Y, Yin T.

Thromb Res. 2012 Sep;130(3):435-40. doi: 10.1016/j.thromres.2012.02.003. Epub 2012 Feb 27.

PMID:
22374335
4.

Polymorphism in CYP2C9 as a non-critical factor of warfarin dosage adjustment in Korean patients.

Lee S, Kim JM, Chung CS, Cho KJ, Kim JH.

Arch Pharm Res. 2003 Nov;26(11):967-72.

PMID:
14661864
6.
7.

[Hemorrhagic complications during warfarin treatment].

Gumulec J, Kessler P, Penka M, Klodová D, Králová S, Brejcha M, Wróbel M, Sumná E, Blatný J, Klaricová K, Riedlová P, Lasota Z.

Vnitr Lek. 2006 Mar;52 Suppl 1:79-91. Review. Czech.

PMID:
16637455
8.

CYP2C9 polymorphism: prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia.

Ngow HA, Wan Khairina WM, Teh LK, Lee WL, Harun R, Ismail R, Salleh MZ.

Singapore Med J. 2009 May;50(5):490-3.

9.

Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.

Deedwania PC, Huang GW.

Am J Cardiovasc Drugs. 2011 Aug 1;11(4):265-75. doi: 10.2165/11592410-000000000-00000. Review.

PMID:
21740079
10.

Comparative study of warfarin versus antiplatelet therapy in patients with a St. Jude Medical valve in the aortic position.

Hartz RS, LoCicero J 3rd, Kucich V, DeBoer A, O'Mara S, Meyers SN, Michaelis LL.

J Thorac Cardiovasc Surg. 1986 Oct;92(4):684-90.

PMID:
3762199
11.

CYP2C9 polymorphism and warfarin sensitivity in Taiwan Chinese.

Chern HD, Ueng TH, Fu YP, Cheng CW.

Clin Chim Acta. 2006 May;367(1-2):108-13. Epub 2006 Jan 17.

PMID:
16413010
12.

Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.

Tischenko A, Gula LJ, Yee R, Klein GJ, Skanes AC, Krahn AD.

Am Heart J. 2009 Aug;158(2):252-6. doi: 10.1016/j.ahj.2009.06.005.

PMID:
19619702
13.

Association of CYP2C9 gene polymorphism with bleeding as a complication of warfarin therapy.

Samardzija M, Topić E, Stefanović M, Zibar L, Samardzija G, Balen S, Vcev A, Domanović D, Mirat J, Barbić J.

Coll Antropol. 2008 Jun;32(2):557-64.

PMID:
18756910
14.

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group.

Fihn SD, McDonell M, Martin D, Henikoff J, Vermes D, Kent D, White RH.

Ann Intern Med. 1993 Apr 1;118(7):511-20.

PMID:
8280198
15.

Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin.

Berlowitz DR, Miller DR, Oliveria SA, Cunningham F, Gomez-Caminero A, Rothendler JA.

Pharmacoepidemiol Drug Saf. 2006 Nov;15(11):799-807.

PMID:
16892457
16.

Genetic polymorphism in exon 4 of cytochrome P450 CYP2C9 may be associated with warfarin sensitivity in Chinese patients.

Leung AY, Chow HC, Kwong YL, Lie AK, Fung AT, Chow WH, Yip AS, Liang R.

Blood. 2001 Oct 15;98(8):2584-7.

17.

Pulmonary vein antrum isolation for atrial fibrillation on therapeutic coumadin: special considerations.

Gopinath D, Lewis WR, Di Biase L, Natale A.

J Cardiovasc Electrophysiol. 2011 Feb;22(2):236-9. doi: 10.1111/j.1540-8167.2010.01940.x. Epub 2010 Nov 2.

PMID:
21044211
18.

Impact of CYP2C9 genetic polymorphism on warfarin dose requirements in Pakistani population.

Siddiqi A, Khan DA, Khan FA, Naveed AK.

Pak J Pharm Sci. 2010 Oct;23(4):417-22.

PMID:
20884456
19.

Surgical workload, risk factors and complications in patients on warfarin with gastrointestinal bleeding.

Som R, Gossage JA, Crane A, Rowe PH.

Int J Surg. 2010;8(1):52-5. doi: 10.1016/j.ijsu.2009.10.010. Epub 2009 Oct 31.

20.

Supplemental Content

Support Center